Orexo AB
Developing innovative medicines using proprietary drug delivery technology.
Oversigt
- 50–99
- Medarbejdere
- 100–500mio SEK
- Omsætning
- 1994
- Grundlagt
Nøglebeslutningstagere
Greta Alina Kampe
Director Business Development
Lena Wange
IR & Corporate Communications Director
Robert A. DeLuca
President Orexo US Inc.
Robert Coburn
Head of Business Development
+9 flere kontakter i Funnelfeedr
Beskrivelse
Orexo is a Swedish biotechnology company focused on advancing treatments for severe diseases and developing life-saving rescue medications. The core of their innovation lies in their proprietary AmorphOX ® drug delivery technology. This technology significantly improves the bioavailability and stabi...